Abstract:OBJECTIVE:To isolate and identify the side population (SP) cells in pancreatic cancer and investigate the role of phosphatidylinositol 3-kinase/mammalian target of rapamycin (PI3K/mTOR) pathway in the survival and proliferation of them.METHODS:Pancreatic cancer cell of the lines PANC-1, BXPC-3, ASPC-1, PC-3, and SW-1990 were cultured. Hoechst 33432 staining and fluorescence-activated cell sorter (FACS) were used to sort the SP cells. Verapamil, inhibitor of ATP binding cassette (ABC) transporter, was added before the Hoechst 33342 inoculation to observe its influence on the SP proportion. Media with LY294002, specific inhibitor of P13K, or rapamycin, specific inhibitor of mammalian target of rapamycin (mTOR), were used to culture PANC-1 cells to observe the survival of cells. Twenty-one NOD-SCID mice were randomly divided into 7 equal groups. Four groups were inoculated subcutaneously with SP cells of the concentrations of 5x10(5), 5x10(4), 5x10(3), or 1x10(3) at the right axillary fossa and with non-SP cells at the left then Hoechst 33342 staining, flow cytometric sorting were used to detect the content of SP cells at the left axillary fossa. The other 3 groups were injected subcutaneously with non-Hoechst 33342 treated cells of the concentrations of 5x10(5), 5x10(4), 5x10(3), or 1x10(3) at the right axillary fossa and PBS at the left axillary fossa. Ten weeks later the mice were killed to undergo pathological examination.RESULTS:All cell lines were found to exhibit verapamil-sensitive SP cells except BXPC-3 cells. The SP cell proportion of the PANC-1 cells was 7.84%. No SP cell was found in the cells treated with verapamil. The colony-formation ability of the SP cells was (43.7+/-3.1)%, significantly higher than those of the non-SP cells and cells without Hoechst 33342 cells [(8.3+/-1.6)% and (10.2+/-1.9)% respectively, both P=0.000]. The tumorigenic ability of the SP cells was 100 times as those of the non-SP cells and Hoechst 33342 un-treated cells. After addition of LY294002 and rapamycin the fractions of the SP cells in the in PANC-1 cells decreased from (7.60+/-0.27)% to (1.90+/-0.22)% and (1.14+/-0.20)% respectively, both P=0.000, and they preferentially inhibited the SP cells rather than non-SP cells.CONCLUSION:SP cells are enriched in pancreatic cancer stem-like cells. PI3K/mTOR pathway is critical for pancreatic SP cells maintenance that can be selected as a new target for inhibiting cancer stem-like cells.

Identification of Side Population Cells Like Cancer Stem Cell in Human Pancreatic Cancer Cell Line SW1990

Proteome of Human Colon Cancer Stem Cells: A Comparative Analysis

Isolation and Identiffcation of Cancer Stem-Like Side Population Cells in Pancreatic Cancer

Side Population in the Pancreatic Cancer Cell Lines Sw1990 and Cfpac-1 is Enriched with Cancer Stem-Like Cells

Characterization of a Cancer Stem Cell-Like Side Population Derived from Human Pancreatic Adenocarcinoma Cells

Isolation and Tumorigenicity of Side Population Cells Sorted from Hepatocellular Carcinoma Bel-7402 Cell Line

Identification of Side Population Cells in Human Hepatocellular Carcinoma Cell Lines with Stepwise Metastatic Potentials

Identification of cancer side population cells in human cervical cancer cell line and analysis of the characteristics

Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis

Isolation and Identification of A Distinct Side Population Cancer Cells in the Human Epidermal Squamous Cancer Cell Line A431

Primary analysis of side population in human a gastric cancer cell line MKN-28

Study on Side Population Cells in Human Hepatoceilular Carcinoma Cell Line 97H

Stem-like Side Population Cells Exist in Human Gallbladder Carcinoma Cell Line GBC-SD and the Expression of ABCG2

Isolation and Phenotypic Characterization of Cancer Stem-Like Side Population Cells in Colon Cancer.

Isolation, Identification and Proliferation of Side Population Cells in Neuroblastoma

Persistence of Side Population Cells with High Drug Efflux Capacity in Pancreatic Cancer.

Characterization of A Stem Cell Population in Lung Cancer Cell Line Glc-82

Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.

Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996.

[Phosphatidylinositol 3-Kinase/mammalian Target of Rapamycin Pathway is Critical for Survival and Proliferation of Pancreatic Cancer Stem-Like Side Population Cells].

[Isolation and Identification of Side Population Cells in Human Lung Adenocarcinoma Cell Line A549].